Mapping Pathways is a multi-national project to develop and nurture a research-driven, community-led global understanding of the emerging evidence base around the adoption of antiretroviral-based prevention strategies to end the HIV/AIDS epidemic. The evidence base is more than results from clinical trials - it must include stakeholder and community perspectives as well.

15 July 2011

Extensive coverage on breakthrough PrEP results

Earlier this week, two large PrEP studies released results confirming that antiretrovirals (ARVs) can reduce the risk of HIV infection through sexual intercourse by 62-73% among heterosexual couples.

The mainstream media, news websites and independent bloggers have covered this extremely encouraging development extensively. The coverage has brought up important questions around financing and cost, prioritization, and translating clinical research to real-world use. 

Take a look at some of the stories, articles and blog posts across the globe:

Mail & Guardian (South Africa): Daily pill can prevent HIV infection

Times of India (India): Antiretroviral drugs reduce HIV risk

UN Dispatch: An HIV Game Changer – The Rundown Blog: Studies: HIV Meds Can Help Prevent New Infections

Fit Perez Blog (Hilton Perez): New Pill Could Prevent HIV

[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position.]

No comments:

Post a Comment